Global Slip Disc Market Size Study by Type (Thoracic Herniated Discs, Lumbar Herniated Disc, Others), by Diagnosis (Physical Examination, Nerve Conduction Test, Others), by Medications (Therapy, Surgery), and Regional Forecasts 2022-2032
The global Slip Disc Market was valued at approximately USD 7.99 Billion in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2032, driven by advancements in diagnostic technologies, increasing cases of spinal injuries, and the growing geriatric population.
Slip disc, also known as herniated or ruptured disc, occurs when the soft tissue between spinal bones slips out, often pressing on nearby nerves. This condition causes significant pain, loss of motor control, and in some cases, disability. The rising sedentary lifestyle and increasing obesity rates globally are major contributors to the growing incidence of slip disc cases.
The demand for technologically advanced diagnostic devices, including MRI and CT scans, is accelerating as they provide precise insights into spinal disorders. Furthermore, government initiatives to enhance healthcare infrastructure and increased investment in research and development are creating new growth avenues for the slip disc market. Key players are focusing on developing minimally invasive surgical techniques and innovative therapies, which are expected to transform treatment outcomes.
North America dominates the slip disc market due to its advanced healthcare infrastructure, robust research and development activities, and a higher prevalence of spinal disorders. Europe holds the second-largest market share owing to the availability of skilled medical professionals and rising healthcare expenditure. Meanwhile, the Asia-Pacific region is projected to exhibit the fastest growth rate due to increasing awareness, a rising number of back pain cases, and growing adoption of advanced medical technologies.
Despite these growth opportunities, the market faces challenges such as high treatment costs and a shortage of skilled healthcare professionals. However, emerging markets in Asia-Pacific and Latin America present lucrative opportunities for manufacturers to expand their footprint.
Major Market Players Included in This Report Are:• Medical Devices Business Services, Inc.
• NuVasive, Inc.
• Globus Medical
• Siemens Healthcare Private Limited
• GENERAL ELECTRIC COMPANY
• Koninklijke Philips N.V.
• Hitachi, Ltd.
• Teva Pharmaceutical Industries Ltd.
• Pfizer Inc.
• CANON MEDICAL SYSTEMS CORPORATION
Detailed Segmentation of the Market Is As Follows:
By Type:
• Thoracic Herniated Discs
• Lumbar Herniated Disc
• Others
By Diagnosis:
• Physical Examination
• Nerve Conduction Test
• Others
By Medications:
• Therapy
• Surgery
By Region:
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
• Latin America
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
South Africa
Saudi Arabia
UAE
Rest of MEA
Years considered for the study are as follows:• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032
Key Takeaways:• Market estimates and forecasts for the period 2022-2032.
• Regional and country-level analysis of market trends.
• Detailed insights into segmentation by type, diagnosis, and medications.
• Competitive landscape analysis, including major players' strategies.
• Impact of technological advancements on market dynamics.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.